Medidata Solutions (NASDAQ:MDSO) Lifted to “Buy” at BidaskClub

BidaskClub upgraded shares of Medidata Solutions (NASDAQ:MDSO) from a hold rating to a buy rating in a research note issued to investors on Thursday, BidAskClub reports.

Several other research analysts have also recently issued reports on MDSO. Guggenheim cut shares of Medidata Solutions from a buy rating to a neutral rating and set a $92.25 price objective for the company. in a report on Wednesday, June 12th. William Blair cut shares of Medidata Solutions from an outperform rating to a market perform rating in a report on Wednesday, June 12th. JPMorgan Chase & Co. upgraded shares of Medidata Solutions from an underweight rating to a neutral rating in a report on Wednesday, June 12th. Dougherty & Co cut shares of Medidata Solutions from a buy rating to a neutral rating in a report on Wednesday, May 1st. Finally, Wells Fargo & Co reiterated a hold rating on shares of Medidata Solutions in a report on Thursday, June 13th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company. The stock currently has a consensus rating of Hold and an average price target of $84.27.

Shares of Medidata Solutions stock traded down $0.03 on Thursday, hitting $91.36. The company had a trading volume of 745,353 shares, compared to its average volume of 1,061,919. The business has a 50-day simple moving average of $90.91. The company has a current ratio of 2.56, a quick ratio of 2.57 and a debt-to-equity ratio of 0.27. The stock has a market cap of $5.71 billion, a P/E ratio of 95.17, a PEG ratio of 6.04 and a beta of 1.23. Medidata Solutions has a 52 week low of $60.10 and a 52 week high of $98.60.

Medidata Solutions (NASDAQ:MDSO) last posted its quarterly earnings data on Monday, July 22nd. The company reported $0.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.31. The business had revenue of $180.50 million during the quarter, compared to analysts’ expectations of $179.95 million. Medidata Solutions had a net margin of 6.43% and a return on equity of 8.64%. The business’s revenue was up 15.8% on a year-over-year basis. During the same period last year, the firm posted $0.43 earnings per share. On average, equities analysts expect that Medidata Solutions will post 0.8 EPS for the current year.

In related news, Director Robert Taylor sold 3,294 shares of the firm’s stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $90.88, for a total transaction of $299,358.72. Following the completion of the sale, the director now directly owns 41,757 shares in the company, valued at $3,794,876.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 4.70% of the company’s stock.

A number of large investors have recently modified their holdings of the stock. BlackRock Inc. boosted its holdings in Medidata Solutions by 4.3% during the first quarter. BlackRock Inc. now owns 7,293,413 shares of the company’s stock worth $534,167,000 after buying an additional 297,812 shares in the last quarter. Clearbridge Investments LLC lifted its position in shares of Medidata Solutions by 2.0% in the 1st quarter. Clearbridge Investments LLC now owns 2,545,149 shares of the company’s stock valued at $186,407,000 after acquiring an additional 48,943 shares in the last quarter. Champlain Investment Partners LLC lifted its position in shares of Medidata Solutions by 1.5% in the 1st quarter. Champlain Investment Partners LLC now owns 2,390,155 shares of the company’s stock valued at $175,055,000 after acquiring an additional 35,405 shares in the last quarter. Janus Henderson Group PLC lifted its position in shares of Medidata Solutions by 6.0% in the 1st quarter. Janus Henderson Group PLC now owns 1,837,555 shares of the company’s stock valued at $134,583,000 after acquiring an additional 103,716 shares in the last quarter. Finally, Nikko Asset Management Americas Inc. lifted its position in shares of Medidata Solutions by 16.8% in the 1st quarter. Nikko Asset Management Americas Inc. now owns 1,259,943 shares of the company’s stock valued at $92,278,000 after acquiring an additional 181,553 shares in the last quarter.

About Medidata Solutions

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.

Featured Article: What is a Roth IRA?

Analyst Recommendations for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.